PL2968420T3 - Zastosowanie komórek macierzystych łożyska do leczenia ostrego uszkodzenia nerek - Google Patents

Zastosowanie komórek macierzystych łożyska do leczenia ostrego uszkodzenia nerek

Info

Publication number
PL2968420T3
PL2968420T3 PL14775592T PL14775592T PL2968420T3 PL 2968420 T3 PL2968420 T3 PL 2968420T3 PL 14775592 T PL14775592 T PL 14775592T PL 14775592 T PL14775592 T PL 14775592T PL 2968420 T3 PL2968420 T3 PL 2968420T3
Authority
PL
Poland
Prior art keywords
treatment
stem cells
placental stem
kidney injury
acute kidney
Prior art date
Application number
PL14775592T
Other languages
English (en)
Inventor
Steven A. Fischkoff
Hong-Jung Chen
Original Assignee
Celularity, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celularity, Inc. filed Critical Celularity, Inc.
Publication of PL2968420T3 publication Critical patent/PL2968420T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
PL14775592T 2013-03-14 2014-03-13 Zastosowanie komórek macierzystych łożyska do leczenia ostrego uszkodzenia nerek PL2968420T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361785252P 2013-03-14 2013-03-14
PCT/US2014/025266 WO2014159826A1 (en) 2013-03-14 2014-03-13 Use of placental stem cells in treatment of acute kidney injury
EP14775592.0A EP2968420B1 (en) 2013-03-14 2014-03-13 Use of placental stem cells in treatment of acute kidney injury

Publications (1)

Publication Number Publication Date
PL2968420T3 true PL2968420T3 (pl) 2019-08-30

Family

ID=51625261

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14775592T PL2968420T3 (pl) 2013-03-14 2014-03-13 Zastosowanie komórek macierzystych łożyska do leczenia ostrego uszkodzenia nerek

Country Status (9)

Country Link
US (2) US20160030488A1 (pl)
EP (1) EP2968420B1 (pl)
JP (4) JP2016512555A (pl)
DK (1) DK2968420T3 (pl)
ES (1) ES2703784T3 (pl)
HK (1) HK1220135A1 (pl)
PL (1) PL2968420T3 (pl)
PT (1) PT2968420T (pl)
WO (1) WO2014159826A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019006514A (es) * 2016-12-05 2019-10-30 Celularity Inc Tratamiento de linfedema y afecciones relacionadas a través del uso de las células adherentes placentarias.
US10456419B2 (en) 2017-02-27 2019-10-29 Payman Sadeghi Method for treating migraine headaches
US10932711B2 (en) 2017-02-27 2021-03-02 Payman Sadeghi Method and system for neurohydrodissection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311905B2 (en) * 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US8460650B2 (en) * 2007-02-12 2013-06-11 Anthrogenesis Corporation Treatment of inflammatory diseases using placental stem cells
EP1482787A4 (en) * 2002-02-13 2006-02-15 Anthrogenesis Corp EMBRYONIC TYPE DERIVED STEM CELLS DERIVED FROM MAMMALIAN POST-PARTUM PLACENTA, USES THEREOF, AND METHODS OF TREATMENT BASED ON CELLS OF THIS TYPE
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses
JP5550235B2 (ja) * 2005-12-29 2014-07-16 アントフロゲネシス コーポレーション 胎盤幹細胞集団
US20090306625A1 (en) * 2007-03-09 2009-12-10 Angiodynamics, Inc. Treatment systems and methods for renal-related diseases
UA99152C2 (ru) * 2007-10-05 2012-07-25 Этикон, Инкорпорейтед Восстановление и регенерация почечной ткани с использованием клеток, полученных с человеческой ткани пупочного канатика
TW201703777A (zh) * 2010-04-07 2017-02-01 安瑟吉納西斯公司 利用胎盤幹細胞之血管新生
CN102933221A (zh) * 2010-04-08 2013-02-13 人类起源公司 使用胎盘干细胞治疗结节病
TW201311259A (zh) * 2011-07-15 2013-03-16 Anthrogenesis Corp 利用羊膜衍生附著性細胞治療輻射傷害

Also Published As

Publication number Publication date
DK2968420T3 (da) 2019-01-02
EP2968420A1 (en) 2016-01-20
JP2021038229A (ja) 2021-03-11
US20160030488A1 (en) 2016-02-04
JP2019055955A (ja) 2019-04-11
JP2016512555A (ja) 2016-04-28
JP2023022018A (ja) 2023-02-14
EP2968420B1 (en) 2018-09-05
WO2014159826A1 (en) 2014-10-02
EP2968420A4 (en) 2016-11-23
US20190388478A1 (en) 2019-12-26
US11696930B2 (en) 2023-07-11
HK1220135A1 (zh) 2017-04-28
ES2703784T3 (es) 2019-03-12
PT2968420T (pt) 2019-01-11

Similar Documents

Publication Publication Date Title
HK1222530A1 (zh) 用於皮膚處理的微閉合及相關方法
IL246239A0 (en) Bicyclic heterocyclic compounds and their uses in healing
HK1222552A1 (zh) 索布替羅用於治療髓鞘形成疾病
GB2509710B (en) Photobioreactor and its use in waste water treatment
LT2986308T (lt) Angiotenzino ii derinys hipotenzijai gydyti
GB2516814B (en) Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
HK1220135A1 (zh) 胎盤幹細胞治療急性腎損傷的用途
EP2964227A4 (en) TREATMENT AND PROPHYLAXIS OF RENAL DISEASES
GB201302839D0 (en) Water Treatment
EP2970883A4 (en) IMPROVED PLACENTAL STEM CELLS AND USES THEREOF
HK1209033A1 (zh) 奧地帕西在治療黏多醣症病中的應用
ZA201604412B (en) Water treatment
HK1209097A1 (en) Water treatment
GB201304038D0 (en) Treated cells and therapeutic uses
GB201416965D0 (en) Water treatment
EP3104863C0 (en) SALICYLATE FOR USE IN THE TREATMENT OF CANCER
ZA201406350B (en) Water treatment
GB201322755D0 (en) Bicyclic heterocycle compounds and their uses in therapy
GB201315704D0 (en) Water treatment
GB201314731D0 (en) Water treatment